Research portfolio
Programmes Four programmes in flight: two ThyroidSupport editions sharing a developmental pipeline, the Clinical Diabetes AI work that recently won the Alivizatos best-oral, and the internal clinic infrastructure that backs daily operations.
Ethics 424 GMH IRB · Αριθμ. Πρωτ. 43773 Data EU Q1 2026 Ethics approval; formative cohort opened complete Q2 2026 Interim usability & alignment analysis complete Q1 2027 Public protocol & interim results underway Ethics 424 GMH IRB · Αριθμ. Πρωτ. 43773 Data EU Q1 2026 Ethics approval; formative cohort opened complete Q4 2026 Interim usability & alignment analysis underway Q1 2027 Public protocol & interim results underway Ethics 424 GMH IRB · Αριθμ. Πρωτ. 47266 Data EU Q2 2026 Algorithm freeze · prospective validation begins complete Q4 2026 Prospective validation cohort runs underway Q1 2027 Public protocol & interim results planned ADA 2026 EASD position Internal retrospective validation Read protocol Ethics Prototype · no patient-facing inference Data EU 2026 Q4 Osteoporosis guideline corpus assembly underway 2026 Q4 CoS RAG ingestion scope + access boundaries underway 2027 Q1 Internal proof-of-concept runs planned Shared engine · Diabetes AI Endocrine + bone-health guidelines Audit logging Read protocol Ethics Internal tooling — no patient-facing inference; standard data-handling controls. Data EU 2026 OCR Thyroxine — clinic deployment complete 2025 Appointment scheduling & notifications — clinic deployment complete